Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir.

Trial Profile

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Jul 2010

At a glance

  • Drugs Fosamprenavir; Posaconazole; Ritonavir
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Acronyms EPOS
  • Most Recent Events

    • 28 Jul 2010 Results have been published in the Journal of Antimicrobial Chemotherapy.
    • 19 Feb 2010 Results presented at the 17th Conference on Retroviruses and Opportunistic Infections (CROI).
    • 09 Dec 2009 Status changed from completed to active, no longer recruiting as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top